1. Home
  2. RYTM vs OLN Comparison

RYTM vs OLN Comparison

Compare RYTM & OLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • OLN
  • Stock Information
  • Founded
  • RYTM 2008
  • OLN 1892
  • Country
  • RYTM United States
  • OLN United States
  • Employees
  • RYTM N/A
  • OLN N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • OLN Major Chemicals
  • Sector
  • RYTM Health Care
  • OLN Industrials
  • Exchange
  • RYTM Nasdaq
  • OLN Nasdaq
  • Market Cap
  • RYTM 3.2B
  • OLN 3.0B
  • IPO Year
  • RYTM 2017
  • OLN N/A
  • Fundamental
  • Price
  • RYTM $57.24
  • OLN $20.01
  • Analyst Decision
  • RYTM Strong Buy
  • OLN Buy
  • Analyst Count
  • RYTM 12
  • OLN 17
  • Target Price
  • RYTM $73.58
  • OLN $37.76
  • AVG Volume (30 Days)
  • RYTM 795.0K
  • OLN 2.1M
  • Earning Date
  • RYTM 05-06-2025
  • OLN 05-01-2025
  • Dividend Yield
  • RYTM N/A
  • OLN 3.74%
  • EPS Growth
  • RYTM N/A
  • OLN N/A
  • EPS
  • RYTM N/A
  • OLN 0.91
  • Revenue
  • RYTM $130,126,000.00
  • OLN $6,540,100,000.00
  • Revenue This Year
  • RYTM $45.46
  • OLN $3.00
  • Revenue Next Year
  • RYTM $63.04
  • OLN $4.78
  • P/E Ratio
  • RYTM N/A
  • OLN $23.51
  • Revenue Growth
  • RYTM 68.06
  • OLN N/A
  • 52 Week Low
  • RYTM $35.17
  • OLN $17.66
  • 52 Week High
  • RYTM $68.58
  • OLN $57.77
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 48.62
  • OLN 26.75
  • Support Level
  • RYTM $45.91
  • OLN $17.66
  • Resistance Level
  • RYTM $63.11
  • OLN $24.73
  • Average True Range (ATR)
  • RYTM 3.46
  • OLN 1.30
  • MACD
  • RYTM 0.29
  • OLN -0.57
  • Stochastic Oscillator
  • RYTM 36.33
  • OLN 12.78

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

Share on Social Networks: